Clinical Trials Browser

Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06566755 2024-08-22

Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer

Phase 3 Recruiting

30 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06516133 2024-07-23

OART

Phase 3 Recruiting

494 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06086457 2024-07-16

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

Phase 3 Recruiting

436 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06411171 2024-05-17

Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

Phase 3 Not yet recruiting

36 enrolled

Gastrointestinal

Gastroesophageal Junction Cancer

NCT06402708 2024-05-10

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Phase 3 Recruiting

172 enrolled

Thoracic

Thymoma

NCT01827553 2024-04-11

CONKO-007

Phase 3 Completed

830 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06341621 2024-04-10

Rainbow

Phase 3 Recruiting

1,900 enrolled

Breast

Breast Neoplasms

NCT06350825 2024-04-05

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Phase 3 Recruiting

200 enrolled

Genitourinary

Prostatic Neoplasms, Directly Observed Therapy

NCT05999149 2024-02-21

BCTOP-T-N01

Phase 3 Recruiting

424 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

CHIC-STS01

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

NIRVANA-LUNG

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

TD-NEOE3V3

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

NORAD01

SABR-SYNC

ESO-Nanjing7

GRECCAR8

ECLECTIC

PACHA-02

UPFRONT-NECK

SABR-COMET 10

OliGRAIL

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

PRIME-Lung

TAB-2

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

DARTS

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC

Neoadjuvant SNF Precision Therapy Phase III

SENIOR

SACTION2401

SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer

SPARKLE-L

SENECA

TIL

Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

PembroMetaRT

Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer

OART

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

CONKO-007

Rainbow

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

BCTOP-T-N01